Site map

Print this page

Print this page

Email us

Press releases

Register for our Alert Service if you would like to be alerted when a news release is added to the site.

Date

Title

25 Nov 2011

Novartis files NDA for NVA237 as a treatment for chronic obstructive pulmonary disease (COPD) in Japan

14 Nov 2011

Vectura Group plc - Interim Results for the six months ended 30 September 2011

31 Oct 2011

Date of announcement of Interim Results for the six months ended 30 September 2011

25 Oct 2011

Update on US NDA timelines for NVA237 and QVA149

27 Sep 2011

NVA237 filed in Europe and positive Phase III data at European Respiratory Society Congress

05 Aug 2011

Vectura enters License Agreement for the development and marketing of VR315 in RoW territories

03 Aug 2011

Vectura announces a new US collaboration agreement with a leading international pharmaceutical company for the VR315 combination asthma/COPD therapy

22 Jul 2011

Results of the Annual General Meeting held on 22 July 2011

22 Jul 2011

Vectura Group plc: Interim Management Statement

30 Jun 2011

Phase III study shows once-daily NVA237 is superior to placebo and similar to tiotropium in improving lung function in COPD

28 Jun 2011

Notice of Annual General Meeting, Availability of 2010/11 Annual Report and Change to the Board of Directors

23 May 2011

Vectura Group plc - Preliminary Results

16 May 2011

Date of announcement of Preliminary Results for year ended 31 March 2011

19 Apr 2011

Phase III data show NVA237 significantly improves lung function with good safety profile in COPD patients

25 Mar 2011

VR496 demonstrates anti-inflammatory and mucolytic activity in cystic fibrosis patients

17 Feb 2011

Vectura Group plc – Interim Management Statement

01 Feb 2011

Appointment of Corporate Broker

19 Jan 2011

Vectura appoints Neil Warner as Non-Executive Director and Chair of the Audit Committee